Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oncobiologics nets $32.5mm through IPO

Executive Summary

Oncobiologics Inc. (biosimilars for immune conditions and cancer) netted $32.5mm through its initial public offering of 5.8mm units at $6. Each unit held one share, half of a Series A warrant (each whole warrant is good for one share at $6.60 for nine months) and half of a Series B warrant (each whole Series B warrant is good for one share at $8.50 for two years). The company filed in February and last month announced that it intended to sell 5mm shares at a range of $11-13.
Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies